Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men

Shakunthala Narayanaswamy, Julia K. Prague, Channa N. Jayasena, Deborah A. Papadopoulou, Maria Mizamtsidi, Amar J. Shah, Paul Bassett, Alexander N. Comninos, Ali Abbara, Stephen R. Bloom, Johannes D Veldhuis, Waljit S. Dhillo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Context: A subpopulation of hypothalamic neurons colocalize three neuropeptides, namely kisspeptin, neurokinin B (NKB), and dynorphin, collectively termed KNDy neurons. Animal studies suggest they interact to affect pulsatile GnRH release (KNDy hypothesis); kisspeptin stimulates, NKB modulates, and dynorphin (an opioid) inhibits. Objective: To investigate the KNDy hypothesis in humans, we assessed for the first time the effects of the coadministration of kisspeptin-54, NKB, and an opioid receptor antagonist, naltrexone, on LH pulsatility (surrogate marker for GnRH pulsatility) and gonadotropin release. Design, Setting, and Participants: This was an ethically approved prospective, single-blinded, placebocontrolled study. Healthymalevolunteers (n=5/group) attended our research facility for eight study visits. Intervention and Main Outcome Measure: After 1 hour of baseline blood sampling, participants received a different intervention at each visit: oral 50mgnaltrexone, 8-hour iv infusions of vehicle, 2.56 nmol/kg · hNKB, 0.1 nmol/kg · hkissspeptin-54 (KP) alone and in combination. Frequent blood sampling to measure plasma gonadotropins and sex steroids was conducted and LH pulsatility was determined using blinded deconvolution analysis. Results: All kisspeptin and naltrexone containing groups potently increased LH and LH pulsatility (P < .001 vs vehicle). NKB alone did not affect gonadotropins. NKB+KP had significantly lower increases in gonadotropins compared with kisspeptin alone (P<.01). Naltrexone+KP was the only group to significantly increase LH pulse amplitude (P < .001 vs vehicle). Conclusions: Our results suggest significant interactions between the KNDy neuropeptides on LH pulsatility and gonadotropin release in humans. This has important implications for improving our understanding of GnRH pulse generation in humans.

Original languageEnglish (US)
Pages (from-to)3429-3436
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Neurokinin B
Kisspeptins
Naltrexone
Gonadotropins
Gonadotropin-Releasing Hormone
Dynorphins
Neuropeptides
Neurons
Blood
Neurokinin-3 Receptors
Sampling
Narcotic Antagonists
Deconvolution
Opioid Analgesics
Animals
Biomarkers
Steroids
Outcome Assessment (Health Care)
human KISS1 protein
Plasmas

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Narayanaswamy, S., Prague, J. K., Jayasena, C. N., Papadopoulou, D. A., Mizamtsidi, M., Shah, A. J., ... Dhillo, W. S. (2016). Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men. Journal of Clinical Endocrinology and Metabolism, 101(9), 3429-3436. https://doi.org/10.1210/jc.2016-1911

Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men. / Narayanaswamy, Shakunthala; Prague, Julia K.; Jayasena, Channa N.; Papadopoulou, Deborah A.; Mizamtsidi, Maria; Shah, Amar J.; Bassett, Paul; Comninos, Alexander N.; Abbara, Ali; Bloom, Stephen R.; Veldhuis, Johannes D; Dhillo, Waljit S.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 9, 01.09.2016, p. 3429-3436.

Research output: Contribution to journalArticle

Narayanaswamy, S, Prague, JK, Jayasena, CN, Papadopoulou, DA, Mizamtsidi, M, Shah, AJ, Bassett, P, Comninos, AN, Abbara, A, Bloom, SR, Veldhuis, JD & Dhillo, WS 2016, 'Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men', Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 9, pp. 3429-3436. https://doi.org/10.1210/jc.2016-1911
Narayanaswamy, Shakunthala ; Prague, Julia K. ; Jayasena, Channa N. ; Papadopoulou, Deborah A. ; Mizamtsidi, Maria ; Shah, Amar J. ; Bassett, Paul ; Comninos, Alexander N. ; Abbara, Ali ; Bloom, Stephen R. ; Veldhuis, Johannes D ; Dhillo, Waljit S. / Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 9. pp. 3429-3436.
@article{3d5eb74ff8aa4ca38eddc2d22a92a6d7,
title = "Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men",
abstract = "Context: A subpopulation of hypothalamic neurons colocalize three neuropeptides, namely kisspeptin, neurokinin B (NKB), and dynorphin, collectively termed KNDy neurons. Animal studies suggest they interact to affect pulsatile GnRH release (KNDy hypothesis); kisspeptin stimulates, NKB modulates, and dynorphin (an opioid) inhibits. Objective: To investigate the KNDy hypothesis in humans, we assessed for the first time the effects of the coadministration of kisspeptin-54, NKB, and an opioid receptor antagonist, naltrexone, on LH pulsatility (surrogate marker for GnRH pulsatility) and gonadotropin release. Design, Setting, and Participants: This was an ethically approved prospective, single-blinded, placebocontrolled study. Healthymalevolunteers (n=5/group) attended our research facility for eight study visits. Intervention and Main Outcome Measure: After 1 hour of baseline blood sampling, participants received a different intervention at each visit: oral 50mgnaltrexone, 8-hour iv infusions of vehicle, 2.56 nmol/kg · hNKB, 0.1 nmol/kg · hkissspeptin-54 (KP) alone and in combination. Frequent blood sampling to measure plasma gonadotropins and sex steroids was conducted and LH pulsatility was determined using blinded deconvolution analysis. Results: All kisspeptin and naltrexone containing groups potently increased LH and LH pulsatility (P < .001 vs vehicle). NKB alone did not affect gonadotropins. NKB+KP had significantly lower increases in gonadotropins compared with kisspeptin alone (P<.01). Naltrexone+KP was the only group to significantly increase LH pulse amplitude (P < .001 vs vehicle). Conclusions: Our results suggest significant interactions between the KNDy neuropeptides on LH pulsatility and gonadotropin release in humans. This has important implications for improving our understanding of GnRH pulse generation in humans.",
author = "Shakunthala Narayanaswamy and Prague, {Julia K.} and Jayasena, {Channa N.} and Papadopoulou, {Deborah A.} and Maria Mizamtsidi and Shah, {Amar J.} and Paul Bassett and Comninos, {Alexander N.} and Ali Abbara and Bloom, {Stephen R.} and Veldhuis, {Johannes D} and Dhillo, {Waljit S.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1210/jc.2016-1911",
language = "English (US)",
volume = "101",
pages = "3429--3436",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men

AU - Narayanaswamy, Shakunthala

AU - Prague, Julia K.

AU - Jayasena, Channa N.

AU - Papadopoulou, Deborah A.

AU - Mizamtsidi, Maria

AU - Shah, Amar J.

AU - Bassett, Paul

AU - Comninos, Alexander N.

AU - Abbara, Ali

AU - Bloom, Stephen R.

AU - Veldhuis, Johannes D

AU - Dhillo, Waljit S.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Context: A subpopulation of hypothalamic neurons colocalize three neuropeptides, namely kisspeptin, neurokinin B (NKB), and dynorphin, collectively termed KNDy neurons. Animal studies suggest they interact to affect pulsatile GnRH release (KNDy hypothesis); kisspeptin stimulates, NKB modulates, and dynorphin (an opioid) inhibits. Objective: To investigate the KNDy hypothesis in humans, we assessed for the first time the effects of the coadministration of kisspeptin-54, NKB, and an opioid receptor antagonist, naltrexone, on LH pulsatility (surrogate marker for GnRH pulsatility) and gonadotropin release. Design, Setting, and Participants: This was an ethically approved prospective, single-blinded, placebocontrolled study. Healthymalevolunteers (n=5/group) attended our research facility for eight study visits. Intervention and Main Outcome Measure: After 1 hour of baseline blood sampling, participants received a different intervention at each visit: oral 50mgnaltrexone, 8-hour iv infusions of vehicle, 2.56 nmol/kg · hNKB, 0.1 nmol/kg · hkissspeptin-54 (KP) alone and in combination. Frequent blood sampling to measure plasma gonadotropins and sex steroids was conducted and LH pulsatility was determined using blinded deconvolution analysis. Results: All kisspeptin and naltrexone containing groups potently increased LH and LH pulsatility (P < .001 vs vehicle). NKB alone did not affect gonadotropins. NKB+KP had significantly lower increases in gonadotropins compared with kisspeptin alone (P<.01). Naltrexone+KP was the only group to significantly increase LH pulse amplitude (P < .001 vs vehicle). Conclusions: Our results suggest significant interactions between the KNDy neuropeptides on LH pulsatility and gonadotropin release in humans. This has important implications for improving our understanding of GnRH pulse generation in humans.

AB - Context: A subpopulation of hypothalamic neurons colocalize three neuropeptides, namely kisspeptin, neurokinin B (NKB), and dynorphin, collectively termed KNDy neurons. Animal studies suggest they interact to affect pulsatile GnRH release (KNDy hypothesis); kisspeptin stimulates, NKB modulates, and dynorphin (an opioid) inhibits. Objective: To investigate the KNDy hypothesis in humans, we assessed for the first time the effects of the coadministration of kisspeptin-54, NKB, and an opioid receptor antagonist, naltrexone, on LH pulsatility (surrogate marker for GnRH pulsatility) and gonadotropin release. Design, Setting, and Participants: This was an ethically approved prospective, single-blinded, placebocontrolled study. Healthymalevolunteers (n=5/group) attended our research facility for eight study visits. Intervention and Main Outcome Measure: After 1 hour of baseline blood sampling, participants received a different intervention at each visit: oral 50mgnaltrexone, 8-hour iv infusions of vehicle, 2.56 nmol/kg · hNKB, 0.1 nmol/kg · hkissspeptin-54 (KP) alone and in combination. Frequent blood sampling to measure plasma gonadotropins and sex steroids was conducted and LH pulsatility was determined using blinded deconvolution analysis. Results: All kisspeptin and naltrexone containing groups potently increased LH and LH pulsatility (P < .001 vs vehicle). NKB alone did not affect gonadotropins. NKB+KP had significantly lower increases in gonadotropins compared with kisspeptin alone (P<.01). Naltrexone+KP was the only group to significantly increase LH pulse amplitude (P < .001 vs vehicle). Conclusions: Our results suggest significant interactions between the KNDy neuropeptides on LH pulsatility and gonadotropin release in humans. This has important implications for improving our understanding of GnRH pulse generation in humans.

UR - http://www.scopus.com/inward/record.url?scp=84988963258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988963258&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-1911

DO - 10.1210/jc.2016-1911

M3 - Article

VL - 101

SP - 3429

EP - 3436

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -